Cargando…
Patient-derived xenograft models of breast cancer and their predictive power
Despite advances in the treatment of patients with early and metastatic breast cancer, mortality remains high due to intrinsic or acquired resistance to therapy. Increased understanding of the genomic landscape through massively parallel sequencing has revealed somatic mutations common to specific s...
Autores principales: | Whittle, James R, Lewis, Michael T, Lindeman, Geoffrey J, Visvader, Jane E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323263/ https://www.ncbi.nlm.nih.gov/pubmed/25849559 http://dx.doi.org/10.1186/s13058-015-0523-1 |
Ejemplares similares
-
Cell fate takes a slug in BRCA1-associated breast cancer
por: Lindeman, Geoffrey J, et al.
Publicado: (2011) -
The future of mammary stem cell biology: the power of in vivo transplants
por: Lindeman, Geoffrey J, et al.
Publicado: (2008) -
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
por: Merino, D., et al.
Publicado: (2019) -
Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?
por: Vaillant, François, et al.
Publicado: (2011) -
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022)